Published in World J Surg on June 01, 2014
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis. Langenbecks Arch Surg (2015) 0.83
Ki-67 expression in luminal type breast cancer and its association with the clinicopathology of the cancer. Oncol Lett (2016) 0.79
Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects. Oncotarget (2016) 0.75
Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas. Ann Surg Oncol (2015) 0.75
Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms. Gastroenterol Res Pract (2017) 0.75
An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: a case report. World J Surg Oncol (2015) 0.75
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? World J Clin Oncol (2016) 0.75
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms. PLoS One (2017) 0.75
[Grading of neuroendocrine tumors]. Pathologe (2016) 0.75
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68
Tumour evolution inferred by single-cell sequencing. Nature (2011) 19.13
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.93
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol (2009) 9.27
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology (2012) 3.00
The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am (2011) 2.95
Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol (2012) 2.38
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer (2005) 2.24
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer (2008) 2.08
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol (2010) 2.00
Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res (2008) 1.98
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg (2009) 1.78
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol (2010) 1.74
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer (2009) 1.60
Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol (2000) 1.60
Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol (2011) 1.57
Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol (2014) 1.52
Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer (2011) 1.46
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol (2011) 1.42
Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol (2008) 1.34
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors. J Nucl Med (2012) 1.31
Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol (2008) 1.25
The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg (2011) 1.21
Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices. Am J Surg Pathol (2012) 1.20
Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol (2000) 1.20
Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res (2001) 1.13
The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg (2010) 1.09
Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center. World J Surg (2012) 1.07
Survival and prognostic factors in patients with small bowel carcinoid tumour. Br J Surg (2011) 1.06
Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer (2011) 1.02
Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors. Neuroendocrinology (2009) 1.02
Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol (2008) 1.02
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. Endocr Relat Cancer (2009) 1.01
Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol (2011) 0.98
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer (2013) 0.97
Malignant diathesis from jejunal-ileal carcinoids. Am J Gastroenterol (1989) 0.90
Metachronous double primary cancer after diagnosis of gastric cancer. Cancer Res Treat (2012) 0.88
Thirteen-month registration of patients with gastroenteropancreatic endocrine tumours in France. Neuroendocrinology (2008) 0.87
Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer. Dis Colon Rectum (2013) 0.87
Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa. Br J Cancer (2000) 0.86
Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms. Semin Nucl Med (2012) 0.85
Usefulness of Ki-67 for predicting the metastatic potential of rectal carcinoids. Pathol Int (2006) 0.85
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas. Endocr Relat Cancer (2010) 0.84
Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours. J Clin Pathol (2013) 0.80
Dual primary gastric and colorectal cancer: is the prognosis better for synchronous or metachronous? Am J Clin Oncol (2012) 0.79
Malignant tumors associated with carcinoid tumors of the gastrointestinal tract. J Clin Gastroenterol (1981) 0.75
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet (2000) 2.58
Tuberculosis of the cervix: case presentation and a review of the literature. Sex Transm Infect (2002) 2.27
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet (1994) 2.14
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia. Aliment Pharmacol Ther (2013) 2.13
Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J Mol Med (Berl) (1997) 1.77
Pneumocystis carinii pneumonia with pleurisy, platypnoea and orthodeoxia. Thorax (2003) 1.53
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet (1994) 1.51
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab (1997) 1.31
Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut (2003) 1.23
Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease. Hepatology (1992) 1.22
Liver resection of colorectal metastases in elderly patients. Br J Surg (2010) 1.21
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Management of concomitant hepatic artery injury in patients with iatrogenic major bile duct injury after laparoscopic cholecystectomy. Br J Surg (2008) 1.18
Treatment of primary rectal squamous cell carcinoma by primary chemoradiotherapy: should surgery still be considered a standard of care? Eur J Cancer (2008) 1.18
Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res (1990) 1.16
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10
Characterizing and reporting pelvic floor defects: the revised New York classification system. Int Urogynecol J Pelvic Floor Dysfunct (2000) 1.08
Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med (1995) 1.05
The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review. Clin Exp Metastasis (2012) 1.04
A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol (2013) 1.03
Protracted enteric cryptosporidial infection in selective immunoglobulin A and saccharomyces opsonin deficiencies. Gut (1990) 1.01
Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01
Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol (2000) 1.00
Bloodless hepatectomy technique. HPB (Oxford) (2002) 0.99
A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol (2012) 0.98
Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? Am J Transplant (2007) 0.97
Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2. Bioorg Med Chem Lett (2001) 0.96
Surgical reintervention for differentiated thyroid cancer. Br J Surg (1993) 0.96
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.95
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. J Viral Hepat (2012) 0.94
Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res (2005) 0.94
Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1. Clin Pharmacol Ther (1990) 0.93
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res (1996) 0.92
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1995) 0.92
SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ (2010) 0.92
Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med (1995) 0.91
Effect of antilyphocyte-globulin potency on survival of cadaver renal transplants. Prospective randomised double-blind trial. Lancet (1977) 0.91
Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution disease. Thorax (2004) 0.91
[Surgical therapy of hilar cholangiocarcinoma]. Chirurg (2006) 0.91
Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab (1996) 0.90
Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. Br J Cancer (2010) 0.90
Multiple endocrine neoplasia type 1 (MEN 1) revisited. Virchows Arch (1995) 0.90
Modelling the muscles of the scapula morphometric and coordinate data and functional implications. J Biomech (1996) 0.89
Metabolomic profiling of oesophago-gastric cancer: a systematic review. Eur J Cancer (2013) 0.89
Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol (2003) 0.88
Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab (1996) 0.87
Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring. Aliment Pharmacol Ther (2007) 0.86
Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit. Histopathology (2012) 0.86
Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy. Eur Surg Res (2007) 0.85
Understanding surgical interventions in RCTs: the need for better methodology. Lancet (2013) 0.85
Antecedent history as a predictor of surgical cure of urgency symptoms in mixed incontinence. Obstet Gynecol (1998) 0.85
Timing and risk factors of hepatectomy in the management of complications following laparoscopic cholecystectomy. J Gastrointest Surg (2011) 0.85
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. Transplant Proc (2004) 0.84
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial. J Viral Hepat (2005) 0.84
A method for measuring depression: validity studies on a depression questionnaire. Br J Psychiatry (1972) 0.84
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging (2008) 0.84
The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer. Colorectal Dis (2014) 0.84
Successful sealing of benign esophageal leaks after temporary placement of a self-expanding plastic stent without fluoroscopic guidance. Z Gastroenterol (2006) 0.83
Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus. J Med Virol (1993) 0.83
A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity. J Gen Virol (1991) 0.83
Cloning and expression of an immunodominant region of the hepatitis delta antigen. J Gen Virol (1990) 0.82
Cancer of unknown primary. Recent Results Cancer Res (2008) 0.82
Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Eur J Med Res (2006) 0.82
Discrimination of lymph node metastases using desorption electrospray ionisation-mass spectrometry imaging. Chem Commun (Camb) (2014) 0.82
Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease). Transplantation (2001) 0.82
Percutaneous transhepatic cholecystoduodenal stent for empyema of the gallbladder. Br J Radiol (2009) 0.82
Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes (2000) 0.82
An in situ hybridization, molecular biological and immunohistochemical study of hepatitis delta virus in woodchucks. Hepatology (1991) 0.82
Living donor liver transplantation. HPB (Oxford) (2006) 0.82
Determination of codeine and its metabolites in human blood plasma and in microsomal incubates by high-performance liquid chromatography with ultraviolet detection. J Chromatogr (1989) 0.82
Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma. Nuklearmedizin (2005) 0.82
[Two cystic retroperitoneal lesions mimicking adrenal cysts]. Pathologe (2005) 0.81
Immunization of woodchucks with recombinant hepatitis delta antigen does not protect against hepatitis delta virus infection. Hepatology (1990) 0.80
Iron deposition in liver in zidovudine-related transfusion-dependent anaemia. Lancet (1989) 0.80
Effect of cyclosporin-A in woodchucks with chronic hepatitis delta virus infection. J Med Virol (1992) 0.80
Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies. J Clin Endocrinol Metab (2000) 0.80
High-energy shock waves pyrotherapy. A new concept in extracorporeal tumour therapy. Surg Oncol (1993) 0.79
Pancreatic and peripancreatic somatostatinomas. Ann R Coll Surg Engl (2011) 0.79
Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. Transplant Proc (2004) 0.79
[Early operation as a treatment measure in thyrotoxic crisis]. Chirurg (2001) 0.79
Gallbladder endometriosis as a cause of occult bleeding. World J Gastroenterol (2007) 0.78
Recurrent intestinal bleeding of obscure origin after biliary drainage procedures in pancreatic disease. Eur J Surg (1994) 0.78
CNI-sparing regimens within the liver transplant setting: experiences of a single center. Clin Transpl (2004) 0.78
Selective in vivo transfection of murine biliary epithelia using polycation-enhanced adenovirus. Gene Ther (2000) 0.78
[Multiple endocrine neoplasia type 1 (MEN 1). Molecular genetics, morphology and prognosis]. Pathologe (1994) 0.78
Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases. Eur J Surg Oncol (2013) 0.77
No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma. Langenbecks Arch Surg (1999) 0.77
[Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.77
Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection. Transplant Proc (2003) 0.77
Telomerase activity in neuroendocrine tumors. Int J Surg Investig (2000) 0.77
F175S change and a novel polymorphism in presenilin-1 gene in late-onset familial Alzheimer's disease. Eur Neurol (2002) 0.77
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors. J Clin Endocrinol Metab (1997) 0.76
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancer. Eur J Ultrasound (2003) 0.76
[Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate]. Dtsch Med Wochenschr (2001) 0.76
Disseminated Mycoplasma fermentans in AIDS patients: several case reports. Int J STD AIDS (2000) 0.76
Dermatitis herpetiformis and primary sclerosing cholangitis. Clin Exp Dermatol (1993) 0.75
[Preventive total thyroidectomy in children with MEN-2A syndrome]. Chirurg (1994) 0.75
[Living organ donor transplantation--the German experience in comparison to others]. Chirurg (2003) 0.75